Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose‑finding trial of tolvaptan for carcinomatous edema/ascites
jRCT2080221912Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tolvaptan in malignant ascites, Edema due to malignant disease and hypervolemia (4 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Started Sep 2012; status: completed.
02
Drugs
tolvaptan
03
Conditions
malignant ascitesEdema due to malignant diseasehypervolemia
Beyond the preview
Go deeper on jRCT2080221912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221912.